HIghlights from a CME symposium held during the 2007 XXV ESCRS Congress in Stockholm, Sweden
News
Presbyopia Correcting IOLs (PCIOLs) are perhaps the most significant technological advancement in recent ophthalmic history. These lenses not only provide patients with the option of seeing near, intermediate, and distant objects without dependence on glasses for most of their daily activities - they could also become the single most important cornerstone for building a successful ophthalmic practice, both now and in the foreseeable future.
A controversial decision by NICE to limit the use of the anti-VEGF drug Lucentis in treating patients with wet AMD, is being reconsidered.
Tempted?
December's product news
What's in the news in December?
A round up of December's industry news.
Take a look at what has been happening in the Cataract & Refractive fields in 2007.
Take a look at what happenend in the Glaucoma field in 2007.
Take a look at what excited Retina specialists in 2007.
Take a look at what happened in the Retina field in 2007 and what exciting developments are round the corner in 2008.
Exploring the highs and lows of IOLs during 2007.
Femtosecond lasers, safe, predictable and increasing in popularity but where will the industry go from here?
A look back at what happened in the fields of cataract & refractive surgery in 2007 and what we can look forward to in 2008.
A look at imaging and diagnostics during 2007 and what the future holds.
A look back at what has happened in the field of glaucoma in 2007 and what we can look forward to in 2008.
The World Economic Forum has selected 39 companies as Technology Pioneers for 2008 and NuLens is one of those honoured with this title.
With additional training, optometrists are at least as accurate as junior ophthalmologists in diagnosing glaucoma.
Click here to read Genentech's open letter to ophthalmologists, outlining its reason for imposing restrictions on the use of Avastin.
Advertisement
Advertisement
